hu3s193
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2008 (NCT00617773)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Lewis Y antigenBINDING AGENT
Lewis Y antigen binding agent
- Lewis Y antigenImmunity, passive
Lewis Y antigen immunity, passive
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109506 ↗
Also known as
- hu3s193
- hu3s193
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01370239 | Phase 2 | Nov 1, 2013 | Instituto do Cancer do Estado de São Paulo, Recepta Biopharma |
| NCT00617773 | Phase 2 | May 1, 2008 | Recepta Biopharma |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Recepta Biopharma | For profit | 2 | 1 | 1 | 2008 |
| Instituto do Cancer do Estado de São Paulo | Academic/Hospital | 1 | 1 | 1 | 2013 |
2 organizations
Page 1 / 1